CRISPR/Cas9 system and its applications in nervous system diseases

被引:16
作者
Jiang, Haibin
Tang, Mengyan [1 ]
Xu, Zidi
Wang, Yanan
Li, Mopu
Zheng, Shuyin
Zhu, Jianghu [2 ,3 ,4 ,5 ,6 ]
Lin, Zhenlang [6 ]
Zhang, Min [2 ,3 ,4 ,5 ,6 ]
机构
[1] Wenzhou Med Univ, Sch Med 2, Wenzhou 325035, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Sch Clin Med 1, Wenzhou 325035, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Yuying Childrens Hosp, Sch Med 2, Wenzhou 325027, Zhejiang, Peoples R China
[4] Key Lab Perinatal Med Wenzhou, Wenzhou 325027, Zhejiang, Peoples R China
[5] Key Lab Struct Malformat Children Zhejiang Prov, Wenzhou 325000, Zhejiang, Peoples R China
[6] Wenzhou Med Univ, Affiliated Hosp 2, Basic Med Res Ctr, 109 Xueyuan West Rd, Wenzhou 325027, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
CRISPR/Cas9; Gene editing; Mutation; Neurological diseases; Therapeutics; PROVIDES ACQUIRED-RESISTANCE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MOUSE MODELS; HOMOLOGOUS RECOMBINATION; HUNTINGTONS-DISEASE; DRAVET SYNDROME; GENOMIC DNA; A-BETA; GENE;
D O I
10.1016/j.gendis.2023.03.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) system is an acquired immune system of many bacteria and archaea, comprising CRISPR loci, Cas genes, and its associated proteins. This system can recognize exogenous DNA and utilize the Cas9 protein's nuclease activity to break DNA double -strand and to achieve base insertion or deletion by subsequent DNA repair. In recent years, multiple laboratory and clinical studies have revealed the therapeutic role of the CRISPR/ Cas9 system in neurological diseases. This article reviews the CRISPR/Cas9-mediated gene editing technology and its potential for clinical application against neurological diseases. & COPY; 2023 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:675 / 686
页数:12
相关论文
共 50 条
[31]   Targeting Specificity of the CRISPR/Cas9 System [J].
Tasan, Ipek ;
Zhao, Huimin .
ACS SYNTHETIC BIOLOGY, 2017, 6 (09) :1609-1613
[32]   CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy [J].
Chen, Chen ;
Wang, Zehua ;
Qin, Yanru .
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
[33]   Comprehensive update on applications of CRISPR/Cas9 for hematological diseases [J].
Shi, Huiping ;
Jiang, Min ;
Wang, Zhaoyue .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (08) :11409-11423
[34]   CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy [J].
Chen Chen ;
Zehua Wang ;
Yanru Qin .
Experimental Hematology & Oncology, 12
[35]   CRISPR/Cas9 System and its Research Progress in Gene Therapy [J].
Liu, Wenlou ;
Yang, Chunsheng ;
Liu, Yanqun ;
Jiang, Guan .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (16) :1912-1919
[36]   Editorial: Genome editing applications of CRISPR/Cas9 in metabolic diseases, hormonal system and cancer research [J].
Liu, Pengpeng ;
Huang, Lei ;
Song, Chun-Qing .
FRONTIERS IN ENDOCRINOLOGY, 2023, 14
[37]   Advancements of the CRISPR/Cas9 System in the Treatment of Liver Cancer [J].
Li, Zhuoyu ;
Han, Ziming .
CURRENT PROTEIN & PEPTIDE SCIENCE, 2024, 25 (02) :154-162
[38]   Applications of the CRISPR-Cas9 system in cancer biology [J].
Sanchez-Rivera, Francisco J. ;
Jacks, Tyler .
NATURE REVIEWS CANCER, 2015, 15 (07) :387-395
[39]   CRISPR/Cas9 System 2020 Nobel Prize in Chemistry [J].
Ramachandran, Rajesh .
RESONANCE-JOURNAL OF SCIENCE EDUCATION, 2020, 25 (12) :1669-1680
[40]   Targeted mutagenesis in chicken using CRISPR/Cas9 system [J].
Oishi, Isao ;
Yoshii, Kyoko ;
Miyahara, Daichi ;
Kagami, Hiroshi ;
Tagami, Takahiro .
SCIENTIFIC REPORTS, 2016, 6